Clough Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,580	Closed	-$252K	–	128
2024 Q3	$252K	Hold	3,580	–	–	0.03%	128
2024 Q2	$295K	Hold	3,580	–	–	0.03%	114
2024 Q1	$313K	Hold	3,580	–	–	0.03%	115
2023 Q4	$345K	Hold	3,580	–	–	0.04%	165
2023 Q3	$317K	Sell	3,580 -44,390	-93%	-$3.95M	0.03%	155
2023 Q2	$4.16M	Buy	+47,970	New	+$4.51M	0.42%	72
2019 Q3	–	Sell	-70,689	Closed	-$6.05M	–	102
2019 Q2	$6.05M	Sell	70,689 -700	-1%	-$59.9K	0.59%	62
2019 Q1	$6.34M	Buy	71,389 +10,000	+16%	+$927K	0.55%	63
2018 Q4	$5.23M	Buy	61,389 +25,444	+71%	+$2.42M	0.61%	59
2018 Q3	$3.49M	Sell	35,945 -4,500	-11%	-$449K	0.33%	68
2018 Q2	$3.81M	Buy	40,445 +4,100	+11%	+$359K	0.34%	71
2018 Q1	$2.95M	Sell	36,345 -3,100	-8%	-$266K	0.28%	76
2017 Q4	$3.52M	Sell	39,445 -9,200	-19%	-$800K	0.29%	70
2017 Q3	$4.53M	Sell	48,645 -1,500	-3%	-$133K	0.3%	75
2017 Q2	$4.55M	Sell	50,145 -53,364	-52%	-$4.85M	0.32%	72
2017 Q1	$9.09M	Buy	103,509 +5,800	+6%	+$516K	0.58%	54
2016 Q4	$8.09M	Buy	97,709 +33,509	+52%	+$2.88M	0.54%	58
2016 Q3	$5.94M	Buy	64,200 +60,400	+1,589%	+$5.69M	0.31%	90
2016 Q2	$296K	Buy	+3,800	New	+$323K	0.02%	170